VYZNOVA

Swiss trademark · 762699 · Word mark · In force

Register entry

Registration number
762699
Application number
06260/2021
Status
In force
Type
Word mark
Filed
Apr 21, 2021
Registered
Apr 22, 2021
Published
Apr 22, 2021
Protected until
Apr 21, 2031
Priority
05.01.2021 US
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Biologische Gewebekulturen für medizinische Zwecke; biologische Gewebetransplantate; biologische Implantate, nämlich ein lebendes aufbearbeitetes menschliches oder tierisches Bindegewebe; biologisches kultiviertes Gewebe, das zur späteren Implantation bestimmt ist.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 6, 2023

    Holder’s address changed

    Owner
    Aurion Biotech, Inc., 117 E. Louisa St. Suite 561, Seattle, Washington 98102 → Aurion Biotech, Inc., 117 E. Louisa St. Suite 561, Seattle, Washington 98102, USA

    Published in Swissreg on 06.01.2023

  2. Dec 30, 2022

    Transferred

    Owner
    Corneagen Inc., 1200 6th Avenue, Suite 300, 98101 Seattle, Washington, USA → Aurion Biotech, Inc., 117 E. Louisa St. Suite 561, Seattle, Washington 98102

    Published in Swissreg on 30.12.2022

  3. Apr 22, 2021

    Registered

    Published in Swissreg on 22.04.2021

Parties

Holder

Aurion Biotech, Inc.

117 E. Louisa St. Suite 561, Seattle, Washington 98102, US

Agent

Walder Wyss AG

Seefeldstrasse 123 Postfach, 8034 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.